Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Gastrointestinal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04421820
What this trial is testing

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Who this might be right for
Colorectal CancerPancreatic CancerGastric Cancers+1 more
Bold Therapeutics, Inc. 220
Early research (Phase 1)Study completedNCT00543842
What this trial is testing

Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT05807542
What this trial is testing

Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC

Who this might be right for
Esophagus Cancer
Shanghai Zhongshan Hospital 20
Testing effectiveness (Phase 2)Study completedNCT04705818
What this trial is testing

Combining Epigenetic And Immune Therapy to Beat Cancer.

Who this might be right for
Advanced Solid TumorAdvanced Colorectal CarcinomaAdvanced Soft-tissue Sarcoma+2 more
Institut Bergonié 164
Early research (Phase 1)Looking for participantsNCT07619313
What this trial is testing

AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced CholangiocarcinomaLocally Advanced Pancreatic Adenocarcinoma+5 more
Jonsson Comprehensive Cancer Center 46
Early research (Phase 1)Looking for participantsNCT06873659
What this trial is testing

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorGastric CancerLiver Cancer
Qurgen Inc. 96
Testing effectiveness (Phase 2)UnknownNCT02941562
What this trial is testing

A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT

Who this might be right for
Rectal Cancer, Radiotherapy
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 150
Testing effectiveness (Phase 2)Study completedNCT02829918
What this trial is testing

Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

Who this might be right for
Biliary Tract CancerBiliary Tract Neoplasms
H. Lee Moffitt Cancer Center and Research Institute 54
Not applicableUnknownNCT05573282
What this trial is testing

Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 50
Early research (Phase 1)UnknownNCT01218880
What this trial is testing

Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Beijing Protgen Biotechnology Development Co., Ltd. 21
Not applicableStudy completedNCT04789980
What this trial is testing

Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Boryung Pharmaceutical Co., Ltd 799
Testing effectiveness (Phase 2)Ended earlyNCT04203641
What this trial is testing

L-DOS47 Plus Doxorubicin in Advanced Pancreatic Cancer

Who this might be right for
Pancreas Cancer
Helix BioPharma Corporation 28
Not applicableUnknownNCT02734680
What this trial is testing

IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 70
Testing effectiveness (Phase 2)Study completedNCT02501603
What this trial is testing

Afatinib, Paclitaxel, 2nd Line, Advanced Gastric Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction Cancer
Yonsei University 72
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04172779
What this trial is testing

Erlotinib for Hepatocellular Carcinoma Chemoprevention

Who this might be right for
Cirrhosis, LiverAdvanced Liver Fibrosis
University of Texas Southwestern Medical Center 60
Large-scale testing (Phase 3)UnknownNCT02960061
What this trial is testing

Perioperative Chemotherapy Combined With HIPEC for High-risk Advanced Gastric Cancer

Who this might be right for
Survival
Sixth Affiliated Hospital, Sun Yat-sen University 640
Not applicableUnknownNCT02219854
What this trial is testing

Single-center Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Third Affiliated Hospital, Sun Yat-Sen University 178
Testing effectiveness (Phase 2)UnknownNCT00081536
What this trial is testing

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Who this might be right for
Colorectal Neoplasms
Aronex Pharmaceuticals 105
Large-scale testing (Phase 3)Study completedNCT01830621
What this trial is testing

BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma

Who this might be right for
Colorectal Carcinoma
NCIC Clinical Trials Group 282
Early research (Phase 1)Study completedNCT00093444
What this trial is testing

Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors

Who this might be right for
Liver CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 30
Next Page